Antiplatelet agents and proton pump inhibitors – personalizing treatment

INTRODUCTION: Antiplatelet therapy remains one of the cornerstones in the management of non-cardioembolic ischemic stroke. However, a significant percentage of patients have concomitant gastroesophageal reflux or peptic ulcer disease that requires acid-reducing medications, the most powerful and eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Eugene, Padmanabhan, Rajiv, Moonis, Majaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513212/
https://www.ncbi.nlm.nih.gov/pubmed/23226046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513212/
https://www.ncbi.nlm.nih.gov/pubmed/23226046

Ejemplares similares